Session 88 - CROI 2009

Session 88 Poster Abstracts
Clinical Studies and Therapy of CNS Infection
Wednesday, 1-2:30 pm
Poster Hall

474	High Prevalence of Mild Neurocognitive Disorders in HIV-infected Patients, ANRS CO3 Aquitaine Cohort Fabrice Bonnet*^1,2,3, H Amieva¹, M Bruyand^1,2,3, F-A Dauchy^2,3, P Morlat^1,2,3, F Dabis^1,2,3, P Mercié^1,2,3, J-F Dartigues¹, G Chêne^1,2,3, C Lewden^1,3, and the ANRS CO3 Aquitaine Cohort ¹INSERM U897, Bordeaux, France; ²CHU de Bordeaux, France; and ³Univ Victor Segalen Bordeaux 2, ISPED, France
475	CCL3L1 Gene Copy Number: The Northeast AIDS Dementia Cohort and the National NeuroAIDS Tissue Consortium Amanda Brown*¹, R Skolasky¹, K Marder², B Cohen³, G Schifitto⁴, J Creighton¹, L Guo¹, and J McArthur¹ ¹Johns Hopkins Univ Sch of Med, Baltimore, MD, US; ²Columbia Univ, New York, NY, US; ³Northwestern Univ, Chicago, IL, US; and ⁴Univ of Rochester, NY, US
476	1-Year Clinical History of CD4 and Viral Load Measures Predicts Current Cognitive Performance among HIV-infected Patients D Tate^1,2, A Delong³, R Paul⁴, K Kertesz¹, J Conley¹, Troy Russell*¹, J Price¹, D McCaffrey¹, J Hogan³, and K Tashima³ ¹Ctr for Neurological Imaging, Brigham and Women`s Hosp, Boston, MA, US; ²Alzheimer`s Disease Ctr, Boston Univ Med Ctr, MA, US; ³Warren Alpert Med Sch, Brown Univ, Providence, RI, US; and ⁴Univ of Missouri, St Louis, US
477	Neurocognitive Impairment in a Romanian Cohort of Children and Young Adults Infected with HIV-1 Clade F D Duiculescu¹, Luminita Ene*¹, R Burlacu¹, C Marin¹, G Tardei¹, T Marcotte², R Ellis², I Everall², and C Achim² ¹Victor Babes Hosp for Infectious Diseases, Bucharest, Romania and ²HIV Neurobehavioral Res Ctr, Univ of California, San Diego, US
478	Substance Use and HIV Infection: Neurocognitive Effect, the CHARTER Cohort Desiree Byrd*¹, S Morgello¹, D Franklin², R Heaton², and I Grant² ¹Mt Sinai Sch of Med, New York, NY, US and ²HIV Neurobehavioral Res Ctr, Univ of California, San Diego, US
479	Fatigue in HIV-infected Individuals Enrolled in A5090: Clinical, Laboratory, and Neuroimaging Characteristics Giovanni Schifitto*¹, L Deng², T-M Yeh², S Evans², and D Clifford³ ¹Univ of Rochester, NY, US; ²Harvard Sch of Publ Hlth, Boston, MA, US; and ³Washington Univ, St Louis, MO, US
480	Cortical and Subcortical Volumes on Magnetic Resonance Imaging Associated with HIV History and Current Disease Status R Cohen¹, Jaroslaw Harezlak*², D Tate³, C Yiannoutosos², M Taylor⁴, G Schifitto⁵, C Guttmann³, G Hana¹, U Clark¹, B Navia⁶, and HIV Neuroimaging Consortium ¹Warren Alpert Med Sch, Brown Univ, Providence, RI, US; ²Indiana Univ Sch of Med, Indianapolis, US; ³Harvard Med Sch, Boston, MA, US; ⁴Univ of California, San Diego Med Ctr, US; ⁵Univ of Rochester Sch of Med, NY, US; and ⁶Tufts Univ Sch of Med, Boston, MA, US
481	Gross and Regional Morphometry of the Midsagittal Corpus Callosal Area in HIV-infected Patients on Stable ART T Russell¹, M Sampat¹, David Tate*¹, J Conley¹, J Price¹, S Barth¹, M Siegel¹, S Rangarajan¹, C Guttmann¹, and B Navia² ¹Ctr for Neurological Imaging, Brigham and Women`s Hosp, Boston, MA, US and ²Tufts Med Ctr, Boston, MA, US
482	Point-of-Care Tests for Diagnosis of Neurosyphilis Christina Marra*, K Hall, L Tantalo, S Sahi, and T Jones Univ of Washington, Seattle, US
483	Intrathecal Immune Activation and Viral Changes in HIV-infected Naïve Patients with Advanced Disease after Short-term HAART Introduction Monica Airoldi*¹, E Suardi¹, A Soria¹, N Squillace¹, S Melzi¹, M Gregorio², D Trabattoni³, M Clerici³, A Gori¹, and A Bandera¹ ¹Division of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University Milano-Bicocca, Monza, Italy; ²Don Carlo Gnocchi Foundation, Milan, Italy; and ³Department of Preclinical Sciences, Chiar of Immunology, University of Milan, Milan, Italy
484a	HIV-related Meningoencephalitis in Patients with Optimally Suppressed Plasma HIV RNA Receiving Stable ART Ana Canestri*¹, X Lescure², S Jaureguiberry¹, A Moulinier², C Amiel², V Calvez¹, G Peytavin³, R Tubiana¹, C Katlama¹, and G Pialloux² ¹Pitié Salpétrière, Paris, France; ²Hosp Tenon, Paris, France; and ³Hopital Bichat Claude Bernard
484b	Persistent HIV in the Central Nervous System during Treatment is Associated with Worse ART Penetration and Cognitive Impairment Scott Letendre*¹, D McClernon², R Ellis¹, J Muñoz-Moreno³, L Way¹, D Franklin¹, R Heaton¹, I Grant¹, and the CHARTER Group ¹Univ of California, San Diego, US; ²McClernon LLC, Cary, NY, US; and ³Hosp Univ Germans Trias i Pujol, Barcelona, Spain
485	Improved Neuropsychological Function during HAART in Diverse Resource-limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study K Robertson¹, H Jiang², S Tripathy³, B Santos⁴, M Silva⁵, S Montano⁶, C Kanyama⁷, C Firnhaber⁸, Scott Evans*², T Campbell⁹, and ACTG 5199 ¹Univ of North Carolina at Chapel Hill, US; ²Harvard Univ, Boston, MA, US; ³Natl AIDS Res Inst, Pune, India; ⁴Group Hosp Conceição, Porto Alegre, Brazil; ⁵Oswaldo Cruz Fndn, Rio de Janeiro, Brazil; ⁶Civil Assn Hits Hlth and Ed, Lima, Peru; ⁷Univ of North Carolina Project, Lilongwe, Malawi; ⁸Univ of the Witwatersrand, Johannesburg, South Africa; and ⁹Univ of Colorado, Denver, US
486	Vicriviroc and Peripheral Neuropathy: Results from ACTG 5211 T-M Yeh¹, S Evans¹, R Gulick², David Clifford*³, and ACTG 5211 Team ¹Harvard Sch of Publ Hlth, Boston, MA, US; ²Weill Med Coll of Cornell Univ, New York, NY, US; and ³Washington Univ, St Louis, MO, US